|
A more recent version of this article appeared on October 31, 2003
Papers In Press, published online ahead of print August 13, 2003
J. Biol. Chem, 10.1074/jbc.M304363200
Submitted on April 25, 2003
Revised on August 12, 2003
Accepted on August 13, 2003
Raloxifene inhibits estrogen-induced up-regulation of telomerase activity in a human breast cancer cell line
Jun Kawagoe, Masahide Ohmichi, Toshifumi Takahashi, Chika Ohshima, Seiji Mabuchi, Kazuhiro Takahashi, Hideki Igarashi, Akiko Mori-Abe, Maki Saitoh, Botao Du, Tsuyoshi Ohta, Akiko Kimura, Satoru Kyo, Masaki Inoue, and Hirohisa Kurachi
Department of Obstetrics and Gynecology, Yamagata University, Yamagata, Yamagata 990-9585
Corresponding Author: masa{at}med.id.yamagata-u.ac.jp
The mechanism by which raloxifene acts in chemoprevention of breast cancer remains unclear. Since telomerase activity is involved in estrogen-induced carcinogenesis, we examined the effect of raloxifene on estrogen-induced up-regulation of telomerase activity in MCF-7 human breast cancer cell line. Raloxifene inhibited the induction of cell growth and telomerase activity by 17b-estradiol (E2). Raloxifene inhibited the E2-induced expression of human telomerase catalytic subunit (hTERT), and transient expression assays using luciferase reporter plasmids containing various fragments of the hTERT promoter showed that the estrogen-responsive element (ERE) appeared to be partially responsible for the action of raloxifene. E2 induced the phosphorylation of Akt, and pretreatment with a phosphatidylinositol 3-kinase (PI3K) inhibitor, LY294002, attenuated the E2-induced increases of the telomerase activity and hTERT promoter activity. Raloxifene inhibited the E2-induced Akt phosphorylation. In addition, raloxifene also inhibited the E2-induced hTERT expression via the PI3K/Akt/NFkB cascade. Moreover, raloxifene also inhibited the E2-induced phosphorylation of hTERT, association of NFkB with hTERT, and nuclear accumulation of hTERT. These results show that raloxifene inhibited the E2-induced up-regulation of telomerase activity not only by transcriptional regulation of hTERT via an ERE-dependent mechanism and the PI3K/Akt/NFkB cascade, but also by post-translational regulation via phosphorylation of hTERT and association with NFkB.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
V. M. Miller and S. P. Duckles
Vascular Actions of Estrogens: Functional Implications
Pharmacol. Rev.,
June 1, 2008;
60(2):
210 - 241.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Kawagoe, M. Ohmichi, S. Tsutsumi, T. Ohta, K. Takahashi, and H. Kurachi
Mechanism of the Divergent Effects of Estrogen on the Cell Proliferation of Human Umbilical Endothelial Versus Aortic Smooth Muscle Cells
Endocrinology,
December 1, 2007;
148(12):
6092 - 6099.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Doshida, M. Ohmichi, S. Tsutsumi, J. Kawagoe, T. Takahashi, B. Du, A. Mori-Abe, T. Ohta, M. Saitoh-Sekiguchi, K. Takahashi, et al.
Raloxifene Increases Proliferation and Up-regulates Telomerase Activity in Human Umbilical Vein Endothelial Cells
J. Biol. Chem.,
August 25, 2006;
281(34):
24270 - 24278.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Kirschenbaum, X.-H. Liu, S. Yao, G. Narla, S. L. Friedman, J. A. Martignetti, and A. C. Levine
Sex steroids have differential effects on growth and gene expression in primary human prostatic epithelial cell cultures derived from the peripheral versus transition zones
Carcinogenesis,
February 1, 2006;
27(2):
216 - 224.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Saitoh, M. Ohmichi, K. Takahashi, J. Kawagoe, T. Ohta, M. Doshida, T. Takahashi, H. Igarashi, A. Mori-Abe, B. Du, et al.
Medroxyprogesterone Acetate Induces Cell Proliferation through Up-Regulation of Cyclin D1 Expression via Phosphatidylinositol 3-Kinase/Akt/Nuclear Factor-{kappa}B Cascade in Human Breast Cancer Cells
Endocrinology,
November 1, 2005;
146(11):
4917 - 4925.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Bjornstrom and M. Sjoberg
Mechanisms of Estrogen Receptor Signaling: Convergence of Genomic and Nongenomic Actions on Target Genes
Mol. Endocrinol.,
April 1, 2005;
19(4):
833 - 842.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Du, M. Ohmichi, K. Takahashi, J. Kawagoe, C. Ohshima, H. Igarashi, A. Mori-Abe, M. Saitoh, T. Ohta, A. Ohishi, et al.
Both estrogen and raloxifene protect against {beta}-amyloid-induced neurotoxicity in estrogen receptor {alpha}-transfected PC12 cells by activation of telomerase activity via Akt cascade
J. Endocrinol.,
December 1, 2004;
183(3):
605 - 615.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|